Owner Boehringer Ingelheim International GmbH

Inventors Dugi, Klaus; Graefe-Mody, Eva Ulrike; Harper, Ruth; Woerle, Hans-Juergen

Agent Spruson & Ferguson

Pub. Number AU-A-2009279085

PCT Pub. Number WO2010/015664

Priority 08161989.2 07.08.08 EP; 08166827.9 16.10.08 EP; 61/105,915 16.10.08 US; 61/086,620 06.08.08 US

Filing date 5 August 2009

Wipo publication date 11 February 2010

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4375 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/522 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism